Krishna Kumar
Works at
12 Sept 2025, reporter.nih.gov
Grants and prizes
National Institute of Diabetes and Digestive and Kidney Diseases
R42, A Robust Platform for Design and Development of Therapeutic Peptides for Metabolic Syndrome, R42DK131842, 2022–2027, 12 Sept 2025, reporter.nih.gov
National Institute of Diabetes and Digestive and Kidney Diseases
R41, Peptide YY triagonist weight loss drugs, R41DK145340, 2025–2027, 26 Aug 2025, reporter.nih.gov
R42, A GIP Companion Drug for Enhancing Metabolic Benefits of Long-Acting GLP-1, R42AG061909, 2018–2025, 4 May 2023, reporter.nih.gov